Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
dorsaVi Limited ( (AU:DVL) ) just unveiled an announcement.
DorsaVi Limited has announced significant progress in its RRAM development program, which is crucial for the company’s future biosensing and edge-intelligent systems. The collaboration with Artemis Labs aims to optimize RRAM for integration at the 22nm technology node, enhancing its performance for neuromorphic and edge-AI applications. This development positions DorsaVi to capitalize on the growing edge AI market, projected to expand significantly by 2030, by providing advanced silicon solutions for wearables, robotics, and industrial safety products.
The most recent analyst rating on (AU:DVL) stock is a Sell with a A$0.04 price target. To see the full list of analyst forecasts on dorsaVi Limited stock, see the AU:DVL Stock Forecast page.
More about dorsaVi Limited
DorsaVi Limited operates in the technology industry, focusing on advanced memory development and biosensing systems. The company is engaged in creating next-generation neuromorphic and edge-AI hardware platforms, leveraging its expertise in Resistive RAM (RRAM) technology to integrate sensing, memory, and computation into compact, low-power silicon solutions.
Average Trading Volume: 6,535,066
Technical Sentiment Signal: Buy
Current Market Cap: A$42.77M
Find detailed analytics on DVL stock on TipRanks’ Stock Analysis page.